ClinicalTrials.Veeva

Menu

Perceptions of E-Cigarettes and Synthetic Cooling Agents, the ICE Study

The Ohio State University logo

The Ohio State University

Status

Enrolling

Conditions

Exposure
Abuse Tobacco

Treatments

Behavioral: Behavioral Intervention
Other: Biospecimen Collection
Other: Survey Administration

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06208202
OSU-23040
NCI-2023-06312 (Registry Identifier)
R01CA276696 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study evaluates how synthetic cooling additives like WS-3 and WS-23 impact e-cigarette perceptions, use behavior, and toxicant exposure.

Full description

PRIMARY OBJECTIVES:

I. Assess the abuse liability of e-liquids with and without the presence of synthetic cooling agents.

II. Determine the impact of synthetic cooling agents and flavor on EC puffing behavior (topography).

III. Determine the exposure ranges (harmful and potentially harmful constituents [HPHCs], other toxicants) from vaping e-liquids with and without the presence of synthetic cooling agents.

OUTLINE:

Participants attend 4 sessions where they receive 1 of 4 randomly assigned flavored e-cigarettes. Participants use the e cigarettes for vaping followed by ad libitum vaping. Participants also complete surveys and undergo biosample collection throughout the study.

Enrollment

300 estimated patients

Sex

All

Ages

21 to 29 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged 21-29 years
  • Current exclusive e-cigarette (EC) user (defined as ≥ weekly use over the past 3 months)
  • Willing to provide informed consent and abstain from using their EC at least 12 hours prior to the four lab sessions
  • Read and speak English

Exclusion criteria

  • Recently COVID-19+ (defined as positive test in the past 30 days) or a recent COVID-19 hospitalization (defined as a hospitalization within the past 6 months)
  • Unstable or significant psychiatric conditions (past and stable conditions will be allowed)
  • History of cardiac event or distress within the past 3 months
  • Are currently pregnant, planning to become pregnant, or breastfeeding (will be verified with urine pregnancy test)
  • Have suffered from any serious lung disease or infection (e.g. , tuberculosis, cystic fibrosis, or lung cancer) in the past 30 days
  • Have hemophilia or another type of bleeding disorder
  • Are blind, severely visually impaired, deaf, hard of hearing, or have a severe motor disability

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

300 participants in 4 patient groups

Fruit flavored e-cigarette with synthetic cooling agents added
Active Comparator group
Description:
Synthetic cooling agents will be added to fruit flavored e-liquid for this condition.
Treatment:
Other: Survey Administration
Other: Biospecimen Collection
Behavioral: Behavioral Intervention
Fruit flavored e-cigarette
Active Comparator group
Description:
Fruit flavored e-liquid will be used for this condition.
Treatment:
Other: Survey Administration
Other: Biospecimen Collection
Behavioral: Behavioral Intervention
Tobacco flavored e-cigarette with synthetic cooling agents added
Active Comparator group
Description:
Synthetic cooling agents will be added to tobacco flavored e-liquid for this condition.
Treatment:
Other: Survey Administration
Other: Biospecimen Collection
Behavioral: Behavioral Intervention
Tobacco flavored e-cigarette
Active Comparator group
Description:
Tobacco flavored e-liquid will be used for this condition.
Treatment:
Other: Survey Administration
Other: Biospecimen Collection
Behavioral: Behavioral Intervention

Trial contacts and locations

1

Loading...

Central trial contact

The Ohio State Comprehensive Cancer Center

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems